Paul W Sandman - Net Worth and Insider Trading
Paul W Sandman Net Worth
The estimated net worth of Paul W Sandman is at least $15 Million dollars as of 2024-11-11. Paul W Sandman is the SVP and General Counsel of Boston Scientific Corp and owns about 166,188 shares of Boston Scientific Corp (BSX) stock worth over $15 Million. Details can be seen in Paul W Sandman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul W Sandman has not made any transactions after 2003-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul W Sandman
Paul W Sandman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul W Sandman owns 2 companies in total, including PDL BioPharma Inc (PDLI) , and Boston Scientific Corp (BSX) .
Click here to see the complete history of Paul W Sandman’s form 4 insider trades.
Insider Ownership Summary of Paul W Sandman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PDLI | PDL BioPharma Inc | 2019-06-20 | director |
| BSX | Boston Scientific Corp | 2003-12-15 | Sr. VP and General Counsel |
Paul W Sandman Latest Holdings Summary
Paul W Sandman currently owns a total of 1 stock. Paul W Sandman owns 166,188 shares of Boston Scientific Corp (BSX) as of December 15, 2003, with a value of $15 Million.
Latest Holdings of Paul W Sandman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BSX | Boston Scientific Corp | 2003-12-15 | 166,188 | 88.25 | 14,666,091 |
Holding Weightings of Paul W Sandman
Paul W Sandman Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul W Sandman has made a total of 0 transactions in Boston Scientific Corp (BSX) over the past 5 years. The most-recent trade in Boston Scientific Corp is the sale of 50,000 shares on December 15, 2003, which brought Paul W Sandman around $2 Million.
Insider Trading History of Paul W Sandman
- 1
Paul W Sandman Trading Performance
Paul W Sandman Ownership Network
Ownership Network List of Paul W Sandman
Ownership Network Relation of Paul W Sandman
Paul W Sandman Owned Company Details
What does PDL BioPharma Inc do?
Who are the key executives at PDL BioPharma Inc?
Paul W Sandman is the director of PDL BioPharma Inc. Other key executives at PDL BioPharma Inc include President and CEO Dominique Monnet , VP & Gen. Counsel & Secretary Christopher Lewis Stone , and VP Finance & CAO and Acting CFO Edward Imbrogno .
PDL BioPharma Inc (PDLI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PDL BioPharma Inc (PDLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDL BioPharma Inc (PDLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PDL BioPharma Inc (PDLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
PDL BioPharma Inc Insider Transactions
Paul W Sandman Mailing Address
Above is the net worth, insider trading, and ownership report for Paul W Sandman. You might contact Paul W Sandman via mailing address: C/o Pdl Biopharma, Inc., 932 Southwood Blvd, Incline Village Nv 89451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
